CAH Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q3

FY2026Q4

64.88B

+17.4%

2.296

+18.96%

62.77B

+14.38%

2.691

+14.52%

66.78B

+11%

2.287

+9.97%

Estimates Revision

The market is revising Upward the revenue expectations for Cardinal Health, Inc. (CAH) for FY2026, with the revenue forecasts being adjusted by 3.9% over the past three months. During the same period, the stock price has changed by 32.66%.

Revenue Estimates for FY2026

Revise Upward

+3.9%

In Past 3 Month

EPS Estimates for FY2026

Revise Upward

+4.19%

In Past 3 Month

Stock Price

Go Up

+32.66%

In Past 3 Month

11 Analyst Rating

Wall Street analysts forecast CAH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAH is 213.91 USD with a low forecast of 187.00 USD and a high forecast of 232.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

2 Hold

0 Sell

Strong Buy

Current: 199.350

Low

187.00

Averages

213.91

High

232.00

Current: 199.350

Low

187.00

Averages

213.91

High

232.00

Barclays

Glen Santangelo

Overweight

initiated

$243

2025-12-08

Reason

Barclays

Glen Santangelo

Price Target

$243

2025-12-08

initiated

Overweight

Reason

Barclays analyst Glen Santangelo initiated coverage of Cardinal Health with an Overweight rating and $243 price target. The firm started the U.S healthcare technology and distribution industry with a neutral view. Barclays is most bullish on the drug distributors and has a more mixed view of the dental and healthcare information technology sub-sectors.

Morgan Stanley

NULL -> Overweight

maintain

$190 -> $224

2025-11-07

Reason

Morgan Stanley

Price Target

$190 -> $224

2025-11-07

maintain

NULL -> Overweight

Reason

Morgan Stanley raised the firm's price target on Cardinal Health to $224 from $190 and keeps an Overweight rating on the shares.

TD Cowen

Charles Rhyee

maintain

$183 -> $225

2025-11-03

Reason

TD Cowen

Charles Rhyee

Price Target

$183 -> $225

2025-11-03

maintain

Reason

TD Cowen analyst Charles Rhyee raised the firm's price target on Cardinal Health to $225 from $183 and keeps a Buy rating on the shares. The firm update their estimates following a F1Q26 where the company raised its adj. EPS guide, Pharma guide, and Other AOI guide.

Jefferies

Buy

maintain

$190 -> $220

2025-11-03

Reason

Jefferies

Price Target

$190 -> $220

2025-11-03

maintain

Buy

Reason

Jefferies raised the firm's price target on Cardinal Health to $220 from $190 and keeps a Buy rating on the shares. The firm notes the company delivered a strong Q3, raising guidance and, most importantly, delivering strong core Pharma numbers against a low buy-side bar. Despite the raise, FY26 guidance still looks conservative to Jefferies, given the strong Q1 performance even after accounting for modest accretion from the now closed Solaris acquisition. The firm remains bullish, as Cardinal Health continues to execute on its strategic priorities with line of sight to achieve its +12%-14% EPS LRP.

Mizuho

Steven Valiquette

Outperform

maintain

$170 -> $210

2025-11-03

Reason

Mizuho

Steven Valiquette

Price Target

$170 -> $210

2025-11-03

maintain

Outperform

Reason

Mizuho analyst Steven Valiquette raised the firm's price target on Cardinal Health to $210 from $170 and keeps an Outperform rating on the shares. With greater momentum following the company's fiscal Q1 report and the Solaris deal, the firm raised its FY26 EPS estimate to $9.80 from $9.40 and its FY27 estimate to $11.20 from $10.60, the analyst tells investors.

UBS

Buy

maintain

$185 -> $220

2025-10-31

Reason

UBS

Price Target

$185 -> $220

2025-10-31

maintain

Buy

Reason

UBS raised the firm's price target on Cardinal Health to $220 from $185 and keeps a Buy rating on the shares. The firm updated its model following the Q1 results.

Valuation Metrics

The current forward P/E ratio for Cardinal Health Inc (CAH.N) is 19.83, compared to its 5-year average forward P/E of 12.88. For a more detailed relative valuation and DCF analysis to assess Cardinal Health Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

12.88

Current PE

19.83

Overvalued PE

15.55

Undervalued PE

10.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

8.71

Current EV/EBITDA

13.06

Overvalued EV/EBITDA

10.30

Undervalued EV/EBITDA

7.12

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.11

Current PS

0.18

Overvalued PS

0.13

Undervalued PS

0.08

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 9666.43% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 9666.43% over the last month.

Sold

Bought

CAH News & Events

Events Timeline

No data

News

8.0

12-05CNBC

Wolfe: These Dividend Aristocrats Regularly Repurchase Their Shares

7.5

12-05NASDAQ.COM

BD Stock Rises Following Partnership to Enhance Hazardous Drug Contamination Testing

6.5

12-05NASDAQ.COM

Why You Should Consider Adding Omnicell Stock to Your Portfolio Today

People Also Watch

Frequently Asked Questions

What is Cardinal Health Inc (CAH) stock price today?

The current price of CAH is 199.35 USD — it has increased 0.59 % in the last trading day.

What is Cardinal Health Inc (CAH)'s business?

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

What is the price predicton of CAH Stock?

What is Cardinal Health Inc (CAH)'s revenue for the last quarter?

Cardinal Health Inc revenue for the last quarter amounts to 64.01B USD, increased 22.44 % YoY.

What is Cardinal Health Inc (CAH)'s earnings per share (EPS) for the last quarter?

Cardinal Health Inc. EPS for the last quarter amounts to 1.88 USD, increased 10.59 % YoY.

What changes have occurred in the market's expectations for Cardinal Health Inc (CAH)'s fundamentals?

How many employees does Cardinal Health Inc (CAH). have?

Cardinal Health Inc (CAH) has 57700 emplpoyees as of December 15 2025.

What is Cardinal Health Inc (CAH) market cap?

Today CAH has the market capitalization of 47.09B USD.